Prevention of Future Deaths reports · 2021

Kyle Hurst

Regulation 28 report to prevent future deaths, reference 2021-0359, written 26 Oct 2021. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report26 Oct 2021
Reference2021-0359
DeceasedKyle Hurst
CoronerJohn Gittins
Coroner areaNorth Wales (East and Central)
CategoryHospital Death (Clinical Procedures and medical management) related deaths · Suicide (from 2015) · Wales prevention of future deaths reports (2019 onwards)
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

John Adrian Gittins 
Senior Coroner for North Wales (East and Central) 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO:  BCUHB, Ysbyty Gwynedd, Penrhosgarnedd, Bangor, 

Gwynedd LL57 2PW 
CORONER 

1 

I am John Adrian Gittins, Senior Coroner for North Wales (East and Central)                     

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and 
regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 

3 

INVESTIGATION and INQUEST 

On the27th of January 2021 I commenced an investigation into the death of Kyle Nicholas 
James Hurst (DOB 8.7.91 DOD 24.1.21) The investigation concluded at the end of the inquest 
on the 22nd of October 2021. The conclusion of the inquest was one of suicide with the cause of 
death being 1(a) Multi Organ Failure 

4 

CIRCUMSTANCES OF THE DEATH 

The circumstances of this death are that the deceased was admitted to Glan Clwyd Hospital on 
the 24th of January 2021 after taking in excess of 
treatment he passed away at the hospital later the same day. 

. Despite receiving 

5 

CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to concern. In my 
opinion there is a risk that future deaths will occur unless action is taken. In the circumstances it 
is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows.  – 

1.  Evidence given at the inquest by the ED Consultant indicated that it has been 

recognised that the accelerated administration of N-Acetylcysteine may be beneficial in 
the treatment of a 
Standard Operating Protocol despite this having been proposed in August 2021 

 but this has not yet been adopted into a 

2.  Following the issue of a regulation 28 report on the 14th of July 2021 in connection with 
the inquest touching upon the death of Rhian Roberts in similar circumstances, the 
response from BCUHB indicated by way of a letter dated the 7th of September 2021 that 
procedures to mitigate risks due to failure to act on diagnostic results would be approved 
and active by the 1st of October 2021, however at the time of concluding the inquest of 
Kyle Hurst on the 22nd of October, this had not been accomplished. 
I am concerned that the Health Board continue to fail to achieve changes in a timely 
manner, even in circumstances where they have set their own timeframe and that as a 
result of this lives are being put at risk. 

3. 

Coroner's Office, County Hall, Wynnstay Road, Ruthin, LL15 1YN 

 
 
 
 
 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 

ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you have the power 
to take such action. 

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this report, namely by 
21st December 2021 I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting out the 
timetable for action. Otherwise you must explain why no action is proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Family of the Deceased and to the Chief Coroner. 

I am also under a duty to send the Chief Coroner a copy of your response.  

The Chief Coroner may publish either or both in a complete or redacted or summary form. He 
may send a copy of this report to any person who he believes may find it useful or of interest. 
You may make representations to me, the coroner, at the time of your response, about the 
release or the publication of your response by the Chief Coroner. 

9 

Dated 26th October 2021 

Signature 

Senior Coroner for North Wales (East and Central) 

Coroner's Office, County Hall, Wynnstay Road, Ruthin, LL15 1YN

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Bcuhb (PDF)
Bloc 5, Llys Carlton, Parc Busnes Llanelwy, 
Llanelwy, LL17 0JG 

---------------------------------- 

Block 5, Carlton Court, St Asaph Business 
Park, St Asaph, LL17 0JG 

Dyddiad / Date:   11th January 2022 

Mr John Gittins  
Senior Coroner 
North Wales (East and Central) 
Coroner's Office 
County Hall 
Wynnstay Road 
Ruthin  
LL15 1YN 

Dear Mr Gittins, 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 
Kyle Nicholas James Hurst  

I write in response to the Regulation 28  Report to Prevent of Future Deaths issued by 
yourself to Betsi Cadwaladr University Health Board, following the inquest touching the 
death of Kyle Hurst.  

I would like to begin by offering my deepest condolences to the family and friends of Mr 
Hurst, and I apologise for the concerns identified at the inquest that have given rise to 
your notice.  

The standard paracetamol antidote is N Acetylcysteine (NAC) given as an infusion. The 
standard  NAC  infusion  regime  is  given  over  21  hours.  There  is  however  mounting 
evidence that this can safely be given over a shorter period of time (12 hours) and this 
accelerated regime is known as the SNAP protocol. The regimes relate to the way the 
antidote is prescribed and given and the main benefit is of reduced length of stay with the 
SNAP regime, it does not however mean initiating the antidote any sooner. 

Although  there  is evidence  accumulating  that  the  accelerated  regime  is safe,  and  it  is 
being used by many UK hospitals now and it is referenced on TOXBASE guidance as an 
option, it is still not officially sanctioned by the MHRA (Medicines & Healthcare products 
Regulatory  Authority).  As  such,  any  local  adoption  of  the  protocol  requires  each 
organisation to locally review and authorise such actions.  Within the Health Board, this 
would  be  after  careful  local  examination  and  consultation  and  formal  approval  at  the 
Drugs and Therapeutics Group.  

At inquest, our witnesses gave evidence that across the Health Board we were working 
to overhaul our paracetamol pathways and to include the SNAP protocol, and the SNAP 
protocol was still going through the process of gaining approval.  

Cyfeiriad Gohebiaeth ar gyfer y Cadeirydd a'r Prif Weithredwr / Correspondence address for Chairman and Chief Executive: 
Swyddfa'r Gweithredwyr / Executives’ Office 
Ysbyty Gwynedd, Penrhosgarnedd 
Bangor, Gwynedd LL57 2PW 

Gwefan: www.pbc.cymru.nhs.uk / Web: www.bcu.wales.nhs.uk 

 
 
 
 
 
 
 
 
 
    
   
    
 
 An updated protocol has been developed and was being formally approved at our Drugs 
and Therapeutics Group in January. However, due to the unexpected wave of COVID 
pressures arising from the Omicron variant and the redeployment of staff to vaccination 
and  front  line  services,  this  meeting  has  been  cancelled.  We  therefore  intend  to  take 
executive decision to approve this procedure outside of the normal governance process 
and this will be completed no later than the 31 January 2022. Once approved, we will 
begin use of the protocol immediately. 

In relation to the procedures to mitigate the risk of not acting upon diagnostic results, we 
have  developed  a  new  Procedure  for  the  Communication  of  Critical  and  Unexpected 
Pathology Results. This document sets out the roles and responsibilities of staff and the 
process to follow. This new procedure has been ratified.  

We  have  had  to  strike  a  balance  between  expediting  the  implementation  of  new 
procedures  whilst  ensuring  proper  governance,  clinical  engagement  and  the  correct 
implementation  of  any  changes.  However  I  hope  the  actions  we  are  taking  to  ensure 
special  approval  gives  you  confidence  we  will  intervene  where  unacceptable  delays 
occur.  

I am concerned to have heard from you that the Health Board has not on a number of 
occasions  met  its  own  deadlines  for  improvement  actions  following  serious  incident 
investigations.  Whilst  the  COVID  pandemic  has  undoubtedly  impacted  us  greatly,  I 
accept this is not an acceptable position and we must improve.  

In April 2021 we changed our serious incident process and this included all investigation 
reports going for scrutiny and approval at an Incident Learning Panel. This new step in 
the process adds an organisational level of scrutiny on all investigations completed by 
our  clinical  divisions  and  we  have  seen  an  improvement  in  the  quality  of  reports  and 
action plans as a result. We are also now tracking actions from these investigation reports 
through our Datix patient safety system and auditing compliance with action completion 
timeframes and evidence.  

This process covers incidents from April 2021 onwards, and so for incidents prior to this 
we  have  appointed  a clinician  to  undertake a  review  of  historic  action plans  to  ensure 
evidence is available against each action. This person commenced in post in November, 
however they have been redeployed to front line services as a result of the current COVID 
wave,  and  we  hope  they  will  be  available  to  return  back  to  this important  work during 
January 2022.  

I hope my letter offers you assurance that we have worked to address the concerns, and 
importantly  that  we  have  a  new  system  in  place  to  provide  greater  oversight  and 
assurance in the future.  

One again, please may  I  offer my  condolences  to  the  loved ones of  Mr Hurst and  my 
apologies for the concerns you have identified.  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Should  you  require  any  further  information  or  evidence  of  the  actions  outlined  above 
please contact either myself or Matthew Joyes, Associate Director of Quality Assurance.   

Yours sincerely 

Prif Weithredwr 
Chief Executive

Related reports

Other reports by John Gittins

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Hospital Death (Clinical Procedures and medical management) related deaths

See every Prevention of Future Deaths report matching Hospital Death (Clinical Procedures and medical management) related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.